
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $133.7M | -- | -- | $0.48 | -- |
08/01/2025 | Q2 | $129.5M | -- | -- | $0.47 | -- |
05/01/2025 | Q1 | $125.4M | $72.7M | $0.29 | $0.47 | -$0.18 |
02/13/2025 | Q4 | $126.2M | $82.3M | $0.37 | $0.50 | -$0.13 |
10/30/2024 | Q3 | $128.1M | $90.4M | $0.42 | $0.51 | -$0.09 |
08/01/2024 | Q2 | $127.5M | $65.3M | $0.25 | $0.51 | -$0.26 |
05/02/2024 | Q1 | $121.9M | $115.7M | $0.57 | $0.50 | $0.07 |
02/15/2024 | Q4 | $117.5M | $139.4M | $0.78 | $0.50 | $0.28 |
11/02/2023 | Q3 | -- | -- | $0.19 | $0.49 | -$0.30 |
08/03/2023 | Q2 | -- | -- | $0.66 | $0.49 | $0.17 |
05/04/2023 | Q1 | -- | -- | $0.68 | $0.46 | $0.22 |
02/16/2023 | Q4 | -- | -- | $0.47 | $0.42 | $0.06 |
11/02/2022 | Q3 | -- | -- | $0.41 | $0.36 | $0.05 |
07/28/2022 | Q2 | -- | -- | -$0.09 | $0.33 | -$0.42 |
05/05/2022 | Q1 | -- | -- | -$0.03 | $0.31 | -$0.34 |
02/22/2022 | Q4 | -- | -- | $0.03 | $0.32 | -$0.29 |
10/28/2021 | Q3 | -- | -- | $0.20 | $0.32 | -$0.12 |
07/29/2021 | Q2 | -- | -- | $0.65 | $0.32 | $0.33 |
04/29/2021 | Q1 | -- | -- | $0.55 | $0.30 | $0.25 |
02/23/2021 | Q4 | -- | -- | $1.31 | $0.33 | $0.98 |
10/29/2020 | Q3 | -- | -- | $0.38 | $0.32 | $0.06 |
07/30/2020 | Q2 | -- | -- | $0.55 | $0.33 | $0.22 |
05/04/2020 | Q1 | -- | -- | -$0.27 | $0.36 | -$0.63 |
02/20/2020 | Q4 | -- | -- | $0.42 | $0.36 | $0.06 |
10/30/2019 | Q3 | -- | -- | $0.18 | $0.34 | -$0.16 |
08/01/2019 | Q2 | -- | -- | -- | $0.33 | -- |
05/02/2019 | Q1 | -- | -- | -- | $0.31 | -- |
02/21/2019 | Q4 | -- | -- | -- | $0.31 | -- |
11/01/2018 | Q3 | -- | -- | -- | $0.31 | -- |
08/02/2018 | Q2 | -- | -- | -- | -- | -- |
05/03/2018 | Q1 | -- | -- | -- | -- | -- |
02/22/2018 | Q4 | -- | -- | -- | -- | -- |
11/02/2017 | Q3 | -- | -- | -- | -- | -- |
08/03/2017 | Q2 | -- | -- | -- | -- | -- |
05/04/2017 | Q1 | -- | -- | -- | -- | -- |
02/23/2017 | Q4 | -- | -- | -- | -- | -- |
11/03/2016 | Q3 | -- | -- | -- | -- | -- |
08/04/2016 | Q2 | -- | -- | -- | -- | -- |
05/05/2016 | Q1 | -- | -- | -- | -- | -- |
02/25/2016 | Q4 | -- | -- | -- | -- | -- |
11/05/2015 | Q3 | -- | -- | -- | -- | -- |
Hercules Capital reported $72.7M worth of top line sales in its most recent quarter.
Hercules Capital announced earnings per share of $0.29 which represents a miss of analyst forecast a $0.47 per share.
Hercules Capital reported -- that represents -- per share over the last quarter.
Hercules Capital's earnings are forecast to grow from $1.61 per share to $2.03 per share next year representing an increase of 18.74%.
Hercules Capital's next earnings date is August 1, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Newegg Commerce [NEGG] is up 17.85% over the past day.